Benzinga | Jul 30, 2021 06:40AM EDT

Immunogen Q2 EPS $(0.15) Beats $(0.18) Estimate, Sales $16.90M Miss $18.92M Estimate

Immunogen (NASDAQ:IMGN) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.18) by 16.67 percent. This is a 7.14 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $16.90 million which missed the analyst consensus estimate of $18.92 million by 10.68 percent. This is a 12.48 percent increase over sales of $15.03 million the same period last year.